{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:49:45Z","timestamp":1761238185062},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":494,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1038\/mt.2015.42","type":"journal-article","created":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T12:23:05Z","timestamp":1429014185000},"page":"1092-1102","source":"Crossref","is-referenced-by-count":5,"title":["Modular Three-component Delivery System Facilitates HLA Class I Antigen Presentation and CD8 + T-cell Activation Against Tumors"],"prefix":"10.1016","volume":"23","author":[{"given":"Benjamin J","family":"Umlauf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Ying","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathlynn C","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2015.42_bib1","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1086\/518006","article-title":"Hemagglutinin protein is a primary target of the measles virus-specific HLA-A2-restricted CD8+ T cell response during measles and after vaccination","volume":"195","author":"Ota","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1038\/mt.2015.42_bib2","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"10.1038\/mt.2015.42_bib3","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/eji.201344272","article-title":"Effect of tumor cells and tumor microenvironment on NK-cell function","volume":"44","author":"Vitale","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1038\/mt.2015.42_bib4","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1101\/gad.169029.111","article-title":"Immune microenvironments in solid tumors: new targets for therapy","volume":"25","author":"Shiao","year":"2011","journal-title":"Genes Dev"},{"key":"10.1038\/mt.2015.42_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1158\/2326-6066.CIR-14-0015","article-title":"Oncolytic viruses and their application to cancer immunotherapy","volume":"2","author":"Chiocca","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1038\/mt.2015.42_bib6","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1076514","article-title":"Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes","volume":"298","author":"Dudley","year":"2002","journal-title":"Science"},{"key":"10.1038\/mt.2015.42_bib7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1305133","article-title":"Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma","volume":"369","author":"Hamid","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2015.42_bib8","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1158\/1078-0432.CCR-12-2733","article-title":"Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cells","volume":"19","author":"Guillerme","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2015.42_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-59745-210-6_9","article-title":"Drug delivery in cancer using liposomes","volume":"437","author":"Dass","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1038\/mt.2015.42_bib10","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1021\/bc500326x","article-title":"Identification of a novel lysosomal trafficking peptide using phage display biopanning coupled with endocytic selection pressure","volume":"25","author":"Umlauf","year":"2014","journal-title":"Bioconjug Chem"},{"key":"10.1038\/mt.2015.42_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF02935312","article-title":"Peptide selection for presentation by HLA class I: a role for the human transporter associated with antigen processing?","volume":"15","author":"van Endert","year":"1996","journal-title":"Immunol Res"},{"key":"10.1038\/mt.2015.42_bib12","doi-asserted-by":"crossref","first-page":"e72938","DOI":"10.1371\/journal.pone.0072938","article-title":"A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density","volume":"8","author":"Gray","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.42_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jconrel.2012.07.013","article-title":"Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?","volume":"164","author":"Taurin","year":"2012","journal-title":"J Control Release"},{"key":"10.1038\/mt.2015.42_bib14","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1038\/srep04480","article-title":"Identification and characterization of a suite of tumor targeting peptides for non-small cell lung cancer","volume":"4","author":"McGuire","year":"2014","journal-title":"Sci Rep"},{"key":"10.1038\/mt.2015.42_bib15","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrm2245","article-title":"Autophagy: from phenomenology to molecular understanding in less than a decade","volume":"8","author":"Klionsky","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1038\/mt.2015.42_bib16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1471-2105-8-178","article-title":"sIR: siRNA Information Resource, a web-based tool for siRNA sequence design and analysis and an open access siRNA database","volume":"8","author":"Shah","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"10.1038\/mt.2015.42_bib17","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2726::AID-IMMU2726>3.0.CO;2-W","article-title":"Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B-fragment of Shiga toxin","volume":"28","author":"Lee","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1038\/mt.2015.42_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-5793(99)00609-2","article-title":"Exploiting retrograde transport of Shiga-like toxin 1 for the delivery of exogenous antigens into the MHC class I presentation pathway","volume":"453","author":"Noakes","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1038\/mt.2015.42_bib19","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.4049\/jimmunol.165.6.3301","article-title":"The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens","volume":"165","author":"Haicheur","year":"2000","journal-title":"J Immunol"},{"key":"10.1038\/mt.2015.42_bib20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1078\/1438-4221-00294","article-title":"Pathways followed by protein toxins into cells","volume":"293","author":"Sandvig","year":"2004","journal-title":"Int J Med Microbiol"},{"key":"10.1038\/mt.2015.42_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrmicro2279","article-title":"Shiga toxins\u2013from cell biology to biomedical applications","volume":"8","author":"Johannes","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1038\/mt.2015.42_bib22","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1021\/cb300119g","article-title":"Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease","volume":"7","author":"McEnaney","year":"2012","journal-title":"ACS Chem Biol"},{"key":"10.1038\/mt.2015.42_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00262-002-0266-6","article-title":"Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors","volume":"51","author":"Lu","year":"2002","journal-title":"Cancer Immunol Immunother"},{"key":"10.1038\/mt.2015.42_bib24","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.4049\/jimmunol.0803458","article-title":"Autophagy and its role in MHC-mediated antigen presentation","volume":"182","author":"Crotzer","year":"2009","journal-title":"J Immunol"},{"key":"10.1038\/mt.2015.42_bib25","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s13238-012-2097-3","article-title":"Intersection of autophagy with pathways of antigen presentation","volume":"3","author":"Patterson","year":"2012","journal-title":"Protein Cell"},{"key":"10.1038\/mt.2015.42_bib26","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The role of autophagy in neurodegenerative disease","volume":"19","author":"Nixon","year":"2013","journal-title":"Nat Med"},{"key":"10.1038\/mt.2015.42_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.cellbio.18.011502.142107","article-title":"Membrane traffic exploited by protein toxins","volume":"18","author":"Sandvig","year":"2002","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1038\/mt.2015.42_bib28","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/sj.clpt.6100389","article-title":"Mass spectrometry and peptide-based vaccine development","volume":"82","author":"Ovsyannikova","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1038\/mt.2015.42_bib29","first-page":"647","article-title":"Vaccination coverage among children in kindergarten-United States, 2011\u201312 school year","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1038\/mt.2015.42_bib30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fimmu.2014.00074","article-title":"Armed therapeutic viruses - a disruptive therapy on the horizon of cancer immunotherapy","volume":"5","author":"Bauzon","year":"2014","journal-title":"Front Immunol"},{"key":"10.1038\/mt.2015.42_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-1-60327-360-2_11","article-title":"Liposome-based vaccines","volume":"605","author":"Schwendener","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1038\/mt.2015.42_bib32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-61779-325-7_16","article-title":"Detection of vaccinia virus-specific IFN\u03b3 and IL-10 secretion from human PBMCs and CD8+ T cells by ELISPOT","volume":"792","author":"Umlauf","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1038\/mt.2015.42_bib33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0198-8859(92)90068-X","article-title":"DNA typing for HLA class I alleles: I. Subsets of HLA-A2 and of -A28","volume":"33","author":"Fernandez-Vi\u00f1a","year":"1992","journal-title":"Hum Immunol"},{"key":"10.1038\/mt.2015.42_bib34","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1158\/1940-6207.CAPR-10-0202","article-title":"Melanoma prevention using topical PBISe","volume":"4","author":"Chung","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1038\/mt.2015.42_bib35","first-page":"455","article-title":"A mathematical model for tumor volume evaluation using two-dimensions","volume":"4","author":"Feldman","year":"2009","journal-title":"J Appl Quant"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616301368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616301368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T12:24:00Z","timestamp":1566563040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616301368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1525001616301368"],"URL":"https:\/\/doi.org\/10.1038\/mt.2015.42","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}